Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine in Individuals at High Risk of Influenza Complications in the 2018–2019 United States Influenza Season

BACKGROUND: Higher rates of influenza-related morbidity and mortality occur in individuals with underlying medical conditions. To improve vaccine effectiveness, cell-based technology for influenza vaccine manufacturing has been developed. Cell-derived inactivated quadrivalent influenza vaccines (cII...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Boikos, Constantina, Imran, Mahrukh, Nguyen, Van Hung, Ducruet, Thierry, Sylvester, Gregg C, Mansi, James A
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2021
Matèries:
Major Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8314952/
https://ncbi.nlm.nih.gov/pubmed/34327253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab167
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars